Clinical Trials Directory

Trials / Conditions / Emphysema

Emphysema

209 registered clinical trials studyying Emphysema27 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPhase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of
NCT07326592
CSL BehringPhase 4
Not Yet RecruitingVentilation-Perfusion Discrepancy Index Versus Conventional Anatomic-Physiologic Assessment for Target Lung Lo
NCT07403617
China-Japan Friendship HospitalN/A
Not Yet RecruitingA Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NCT07119229
Pulmair Medical, Inc.N/A
RecruitingA Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
NCT07086339
Pulmair Medical, Inc.N/A
RecruitingImplementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
NCT07059637
The Cleveland ClinicN/A
Not Yet RecruitingUtilising Hull Lung Health Study Data to Investigate the Performance of TidalSense Diagnostic Algorithms to Id
NCT06788613
Chiesi UK
RecruitingBronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755
Apreo Health, Inc.N/A
Not Yet RecruitingEndobronchial Silicone Valve for Patients With Emphysema
NCT07097896
China-Japan Friendship HospitalN/A
RecruitingThe REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
NCT06655428
Morair Medtech, LLCN/A
RecruitingAnalysing Peripheral Skeletal Muscle Function Before and After Endobronchial Valve Treatment
NCT06025500
University Medical Center Groningen
RecruitingClinical-ultrasonographic Assessment of Pulmonary Emphysema
NCT06533371
Fondazione Policlinico Universitario Agostino Gemelli IRCCSN/A
RecruitingIdentification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Bre
NCT06528418
ChromX Health
Active Not RecruitingLong-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
NCT05897424
SanofiPhase 2
RecruitingSafety and Efficacy of Endobronchial Valve for Bronchoscopic Lung Volume Reduction Surgery: a Prospective Pilo
NCT06349174
China-Japan Friendship HospitalN/A
CompletedAnti-Platelets in Chronic Obstructive Pulmonary Disease
NCT05567562
Brigham and Women's HospitalPhase 2
RecruitingZephyr Valve Japan Post-Marketing Surveillance
NCT06332885
Pulmonx Corporation
RecruitingBiological Effects of Quercetin in COPD Phase II
NCT06003270
Temple UniversityPhase 2
Enrolling By InvitationUsing Artificial Intelligence for the Detection of Respiratory Diseases Associated With Pollution
NCT06512142
University of Medicine and Pharmacy "Victor Babes" Timisoara
CompletedStudy of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema
NCT05856331
SanofiPhase 2
RecruitingExploring Novel Biomarkers for Emphysema Detection
NCT05825261
Maastricht University
TerminatedA Randomized Controlled Trial of InterVapor® in France - The TARGET Trial
NCT05118269
Uptake Medical Technology, Inc.N/A
CompletedEmphysema and FLNA Mutation (E-FLNA)
NCT05550844
University Hospital, Lille
CompletedAssessing the DIAphragM Before ANd After Endobronchial Valve Treatment
NCT04735731
University Medical Center Groningen
RecruitingCharacterizing Matrix Metalloproteinase-12 (MMP12) in Sputum
NCT04761393
McMaster University
Active Not RecruitingDoxycycline for Emphysema in People Living With HIV (The DEPTH Trial)
NCT05382208
Weill Medical College of Cornell UniversityPhase 2
UnknownFunctional Lung Imaging in Patients With Respiratory Compromise Undergoing Endobronchial Valve Placement
NCT05204875
Temple University
Active Not RecruitingA Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema
NCT05087641
Pulmair Medical, Inc.N/A
CompletedPulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes
NCT05610514
University of VermontPhase 2
UnknownStudy on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province
NCT05330637
Shanghai Jiao Tong University School of Medicine
CompletedEvaluation of Immunological, Microbiological and Metabolomic Profiles in COPD
NCT06826560
Medical University of Warsaw
Enrolling By InvitationGlobal Utilization And Registry Database for Improved preservAtion of doNor LUNGs
NCT04930289
Paragonix Technologies
RecruitingSTRIVE Post-Market Registry Study
NCT04302272
Olympus Corporation of the Americas
UnknownEffect of EPAP Device on Emphysema and Lung Bullae
NCT04742114
Qilu Hospital of Shandong UniversityN/A
UnknownThe Lung Microbiome and Endobronchial Valve Treatment
NCT04932811
Aarhus University Hospital
CompletedMind The Gap - Crossing Borders Study
NCT04256408
University Medical Center GroningenN/A
Completed4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting
NCT04786171
Vanderbilt University Medical Center
CompletedFissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status (CONVERT)
NCT04559464
Pulmonx CorporationN/A
TerminatedDeveloping Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
NCT02748798
Thunder Bay Regional Health Research InstituteEARLY_Phase 1
CompletedLung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
NCT04435327
University of Milano Bicocca
RecruitingSurgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema
NCT04537182
Isabelle Opitz, Professor, MDN/A
UnknownRight Ventricular Diastolic Dysfunction
NCT04467242
University Hospital, Montpellier
RecruitingKingston Chronic Obstructive Pulmonary Disease (COPD) Multidimensional Long Term Follow up Cohort
NCT04200079
Dr. Juan Pablo de Torres Tajes
CompletedFeasibility of a Multi Component Intervention in Patients With Severe Dyspnea and Obesity
NCT03836547
Mayo ClinicN/A
Active Not RecruitingZephyr Valve Registry (ZEVR)
NCT04186546
Pulmonx Corporation
UnknownCinenses Lung Volume Reduction Reverser System First-in-man Study Treating Patients With Severe Emphysema
NCT03685526
Lifetech Scientific (Shenzhen) Co., Ltd.N/A
CompletedMortality and Symptom Burden Post Hospitalisation With COPD
NCT03657121
Northumbria Healthcare NHS Foundation Trust
TerminatedHyperinflation Assessment After Treatment by Lung Volume Reduction Coil
NCT02835001
University Hospital, ToulouseN/A
CompletedHome Pulmonary Rehabilitation for COPD
NCT03480386
Mayo ClinicN/A
CompletedA Home-based Intervention to Promote Mindful Breathing Awareness Through Pursed-lip Breathing Training for COP
NCT03814980
Mayo ClinicN/A
CompletedA 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Pla
NCT03636347
Mereo BioPharmaPhase 2
CompletedBelimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies
NCT03244059
University of Alabama at BirminghamPhase 2
CompletedA Trial on the Effects of Bronchoscopic Lung Volume Reduction in Severe Emphysema.
NCT03474471
University Medical Center GroningenN/A
CompletedMechanistic Effects of Health Coaching to Reduce Chronic Obstructive Pulmonary Disease (COPD) Hospitalizations
NCT03837847
Mayo ClinicN/A
WithdrawnMelodica Orchestra for Dyspnea: Safety and Feasibility Pilot
NCT03653104
VA Quality Enhancement Research IntiativeN/A
CompletedComparison of the Effectiveness of Home and Hospital-based PR in Candidate Patients With BLVR
NCT03518177
Istanbul Medipol University HospitalN/A
CompletedStudy of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema
NCT03360396
Boston Scientific CorporationN/A
RecruitingExploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease
NCT03455686
McMaster UniversityN/A
CompletedSmoking Cessation and Functional CT Assessment
NCT03382106
Eric A. HoffmanPhase 4
WithdrawnEvaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant
NCT03111888
The Cleveland ClinicN/A
UnknownLVR in Severe Emphysema Using Bronchoscopic Autologous Blood Instillation in Combination With Intra-bronchial
NCT03010449
Royal Brompton & Harefield NHS Foundation TrustN/A
Active Not RecruitingFunctional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema
NCT02682147
Eric A. HoffmanPhase 4
CompletedImplementing and Evaluating the Genie Tool in COPD
NCT02935452
University of SouthamptonN/A
CompletedLosartan Effects on Emphysema Progression
NCT02696564
JHSPH Center for Clinical TrialsPhase 4
CompletedEfficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Defici
NCT03114020
Gerard TurinoPhase 2
UnknownStudying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD
NCT03010592
Royal Brompton & Harefield NHS Foundation Trust
Active Not RecruitingBROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioI
NCT03049202
Karolinska Institutet
UnknownLung Volume Reduction Coil Microbiome Study
NCT03010566
Royal Brompton & Harefield NHS Foundation Trust
RecruitingSite and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
NCT03263130
Gelb, Arthur F., M.D.
CompletedTargeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
NCT03008915
Columbia UniversityPhase 2
TerminatedEndoscopic Lung Volume Reduction Coil Treatment in Patients With Chronic Hypercapnic Respiratory Failure
NCT02996149
Universitätsklinikum Hamburg-Eppendorf
CompletedClinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System
NCT02877459
Pulmonx CorporationN/A
TerminatedThe Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort
NCT02838108
Duke University
CompletedREACH SVS Control Patient Cross-Over Study
NCT02914340
Olympus Corporation of the AmericasN/A
CompletedHome-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients
NCT02999685
Mayo ClinicN/A
CompletedAdvancing Symptom Alleviation With Palliative Treatment
NCT02713347
VA Office of Research and DevelopmentN/A
CompletedActivity Monitor Use in COPD Patients Undergoing Rehabilitation
NCT02895152
Northern Care Alliance NHS Foundation TrustN/A
CompletedSCCOR Minorities Observational Study
NCT02898272
University of Pittsburgh
UnknownEndobronchial Valve in Patients With Heterogeneous Emphysema
NCT02823223
Chinese PLA General HospitalN/A
CompletedPrevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort
NCT02687997
Instituto de Investigación Sanitaria de la Fundación Jiménez DíazN/A
CompletedComputed Tomography Assessment of Regional Ventilation (CURVE)
NCT02879773
Heart of England NHS Trust
CompletedThe Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD
NCT02099799
VA Office of Research and DevelopmentN/A
TerminatedA Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe
NCT02470052
Olympus CorporationN/A
TerminatedChanges in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treat
NCT02499380
Boston Scientific Corporation
UnknownSpiration Valve System 9 mm European Post Market Evaluation Study
NCT03008226
Heidelberg University
CompletedGenetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome
NCT02439528
Hospices Civils de LyonN/A
CompletedAlpha-1 Carrier Genomics Study
NCT02810327
Medical University of South Carolina
CompletedDoxycycline for COPD in HIV-Infected Patients
NCT01744093
Weill Medical College of Cornell UniversityN/A
CompletedImprovement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema
NCT02399514
Institut für Pneumologie Hagen Ambrock eVN/A
WithdrawnLung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency
NCT02273349
University Hospital, SaarlandN/A
CompletedElectrical Impedance Imaging of Patients on Mechanical Ventilation
NCT02232841
Colorado State University
CompletedLongitudinal Evaluation of HIV-associated Lung Disease Phenotypes
NCT02238327
University of Pittsburgh
RecruitingCOPD Patient-Powered Research Network
NCT02803242
COPD Foundation
CompletedAssessment of Emphysema Using 1.5T MRI With UTE Pulse Sequences
NCT02100800
University Hospital, BordeauxN/A
CompletedMindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease
NCT02042976
University of AarhusN/A
RecruitingDEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema.
NCT06690385
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
CompletedHIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium
NCT02056158
Weill Medical College of Cornell University
CompletedA Safety and Feasibility Study of Re-treating Patients With Severe Emphysema With the RePneu LVRC System.
NCT02012673
University Medical Center GroningenN/A
CompletedProstaglandin Inhibition for Emphysema
NCT02006576
University of NebraskaPhase 2
TerminatedLVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)
NCT02059057
Boston Scientific CorporationN/A
CompletedSafety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary
NCT01953523
Elliot LanderN/A
WithdrawnStudy of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emph
NCT01908933
Aeris TherapeuticsPhase 3
CompletedEx-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitab
NCT01615484
University of North Carolina, Chapel HillN/A
CompletedPulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
NCT01796392
Pulmonx CorporationN/A
CompletedSequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study
NCT01719263
Uptake Medical CorpN/A
CompletedEvaluation of the Spiration® Valve System for Emphysema to Improve Lung Function
NCT01812447
Olympus Corporation of the AmericasN/A
TerminatedPost Market Observational, Prospective, Multi-center Study
NCT01806636
Boston Scientific Corporation
CompletedThe Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchit
NCT03073798
Johns Hopkins UniversityPhase 4
UnknownLung Volume Reduction Coil Treatment in Emphysema.
NCT01822795
CHU de ReimsPhase 3
CompletedLung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy
NCT03673176
Stanford UniversityN/A
UnknownBronchoscopic Thermal Saline Ablation (BTSA) of Emphysematous Lung. A New Emphysema Therapy
NCT01920321
Assaf-Harofeh Medical CenterPhase 1 / Phase 2
CompletedThe Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success
NCT04347044
Istanbul Medipol University HospitalN/A
UnknownSafety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patient
NCT01758055
Arda KianiPhase 1
TerminatedLung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
NCT01608490
Boston Scientific CorporationN/A
CompletedEvaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Sub
NCT01421082
Boston Scientific CorporationPhase 2 / Phase 3
CompletedImaging Lung Function Using Oxygen Enhanced MRI
NCT01731015
Hal C CharlesPhase 1
CompletedA Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (EL
NCT01101958
Pulmonx CorporationN/A
UnknownEvaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Functi
NCT01466712
KU LeuvenPhase 4
CompletedBlood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructi
NCT01949181
Hopital FochN/A
CompletedRehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Emphysema
NCT01305668
Villa Pineta Hospital
CompletedHypoxic Pulmonary Vasoconstriction Pilot Study
NCT03733470
Eric A. HoffmanPhase 4
UnknownSunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography
NCT01361984
University of California, Los AngelesPhase 4
CompletedA Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (
NCT01302587
Teva Branded Pharmaceutical Products R&D, Inc.
UnknownEffect of Symbicort on Sleep Quality in Patients With Emphysema
NCT01602523
Temple UniversityPhase 3
CompletedEccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)
NCT01077102
McGill University Health Centre/Research Institute of the McGill University Health CentreN/A
TerminatedA Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema
NCT01449175
Aeris Therapeutics
UnknownEffects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pu
NCT01431625
Hospitales Universitarios Virgen del RocíoPhase 4
TerminatedPhase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
NCT01241942
University of North Carolina, Chapel HillN/A
Active Not RecruitingStudy of COPD Subgroups and Biomarkers
NCT01969344
University of North Carolina, Chapel Hill
CompletedSafety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
NCT01213043
Grifols Therapeutics LLCPhase 2
CompletedSafety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema
NCT01306513
Leiden University Medical CenterPhase 1
CompletedPrognostic Indicators as Provided by the EPIC ClearView
NCT01476995
Epic Research & Diagnostics, Inc.
CompletedStudy on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema
NCT01121367
Beijing Chao Yang Hospital
CompletedRandomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of
NCT01334307
Boston Scientific CorporationPhase 1
CompletedBronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction
NCT01041586
Uptake Medical CorpPhase 1
CompletedInternational Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1
NCT01217671
Kamada, Ltd.Phase 2 / Phase 3
CompletedFeasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)
NCT01328899
Boston Scientific CorporationPhase 1 / Phase 2
CompletedBronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction
NCT01102712
Uptake Medical CorpN/A
CompletedBronchoscopic Lung Volume Reduction Using Blood
NCT01528267
Chelsea and Westminster NHS Foundation TrustPhase 2
UnknownBronchoreversibility and Radiologic Morphology of Emphysema
NCT02008162
University of Rome Tor Vergata
CompletedAeriSeal System for Lung Volume Reduction
NCT01051258
Aeris TherapeuticsPhase 1 / Phase 2
CompletedEvaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
NCT01710449
Hal C CharlesPhase 1
CompletedThe Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and
NCT00974064
Weill Medical College of Cornell University
WithdrawnCryoSpray Ablation(tm)Thoracic Patient Registry
NCT00785239
CSA Medical, Inc.
CompletedLung HIV Disease in a Large Cohort-Pitt
NCT01326572
University of Pittsburgh
CompletedPrevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center
NCT00870857
University of Pittsburgh
CompletedEfficacy of Losartan in Preventing Progression of COPD
NCT00720226
Johns Hopkins UniversityPhase 4
CompletedExtension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor
NCT00670007
CSL BehringPhase 4
UnknownSimvastatin in Chronic Obstructive Pulmonary Disease (COPD)
NCT00680641
University of East AngliaPhase 4
WithdrawnPerforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
NCT00633776
University of California, Los AngelesPhase 4
WithdrawnSequential Endoscopic Lung Volume Reduction
NCT00613860
Heidelberg UniversityPhase 3
CompletedEvaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema
NCT01220908
Boston Scientific CorporationN/A
Active Not RecruitingExamining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
NCT00608764
Brigham and Women's Hospital
CompletedEvaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive
NCT00725309
Washington University School of Medicine
CompletedBiomarkers and Genetic Factors Related to Emphysema
NCT00757120
Washington University School of Medicine
CompletedClinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe E
NCT00475007
Olympus Corporation of the AmericasN/A
SuspendedVibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure
NCT00523094
Deep Breeze
CompletedPneumocystis in Pathogenesis of HIV-associated Emphysema
NCT00869544
University of Pittsburgh
UnknownEUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patient
NCT00730301
LudwLudwig Boltzmann Institute for COPD and Respiratory EpidemiologyPhase 4
Active Not RecruitingClinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease
NCT02627872
Karolinska Institutet
CompletedTESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)
NCT00413205
Hoffmann-La RochePhase 2
CompletedEfficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructiv
NCT00424528
Sumitomo Pharma America, Inc.Phase 4
TerminatedBronchitis and Emphysema Advice and Training to Reduce Hospitalization
NCT00395083
US Department of Veterans AffairsPhase 2
UnknownEASE Trial: Exhale Airway Stents for Emphysema
NCT00391612
Broncus TechnologiesPhase 3
CompletedReal-Time Support for Exercise Persistence in COPD
NCT00373932
University of WashingtonPhase 1 / Phase 2
CompletedAlveolar Macrophage Proteomics in HIV-associated Emphysema
NCT00823927
Philip Diaz
CompletedZemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency
NCT00261833
CSL BehringPhase 4
CompletedSingle-Breath Measurement Underestimates Ventilatory Volume According to Emphysema Severity
NCT00528944
Columbia University
WithdrawnUse of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure
NCT00288964
Alung TechnologiesPhase 3
CompletedSafety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonar
NCT00250679
Sumitomo Pharma America, Inc.Phase 3
CompletedMacrophage Phagocytosis in COPD
NCT00298389
Imperial College London
WithdrawnMacrophages in Smokers' Lung
NCT00298402
Imperial College London
CompletedThe Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD
NCT00406705
University of AlbertaPhase 2
CompletedSildenafil for Chronic Obstructive Pulmonary Disease
NCT00104637
Kawut, Steven, MDPhase 2
UnknownManagement of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema
NCT00700934
Assistance Publique - Hôpitaux de Paris
TerminatedEndobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study
NCT00137956
Emphasys MedicalPhase 3
CompletedImproving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (CO
NCT00106080
VA Office of Research and DevelopmentN/A
UnknownEndothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA
NCT00843271
Columbia University
UnknownAssessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
NCT00129350
Royal Brompton & Harefield NHS Foundation TrustPhase 1
CompletedTiotropium Induced Bronchodilation in Lung CT Scored Emphysema
NCT00570544
Gelb, Arthur F., M.D.
CompletedExhale (R) Stent for Emphysema
NCT00207337
Broncus TechnologiesPhase 2 / Phase 3
TerminatedThorax Enlarging Surgery: a Novel Surgical Approach to Emphysema
NCT00650559
KU LeuvenN/A
CompletedStudy Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Preventio
NCT00188825
University Health Network, TorontoPhase 3
CompletedAirway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
NCT00181207
Johns Hopkins UniversityPhase 4
CompletedLeukocyte Function in Asthma and COPD
NCT00147069
Imperial College London
CompletedDistribution of Regional Lung Function by Vibration Response Imaging
NCT01229020
Deep Breeze
CompletedEvaluation of the Lungs of Individuals With Lung Disease
NCT00224198
Weill Medical College of Cornell University
CompletedEndobronchial Valve for Emphysema Palliation Trial (VENT)
NCT00129584
Emphasys MedicalPhase 3
CompletedPilot Study of the Spiration IBV™ System
NCT00145548
Olympus Corporation of the AmericasPhase 2
TerminatedEvaluating Genes in Sputum to Measure Drug Response in COPD
NCT00233051
National Jewish HealthN/A
CompletedEffectiveness of Different Exercise Training Programs to the Profile of COPD Patients
NCT01336283
Hospitales Universitarios Virgen del RocíoPhase 4
CompletedRegulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease
NCT00147095
Imperial College London
CompletedTo Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD
NCT00064415
Sumitomo Pharma America, Inc.Phase 3
CompletedDetermine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
NCT00064402
Sumitomo Pharma America, Inc.Phase 3
CompletedInhaled Steroid Reduces Systemic Inflammation in COPD
NCT00175565
University of British ColumbiaPhase 4
CompletedRegulation of the Release of Inflammatory Mediators From Lung Macrophages.
NCT00147017
Imperial College London
CompletedEfficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
NCT00034112
National Center for Complementary and Integrative Health (NCCIH)Phase 2
CompletedLeukocyte Function in Chronic Obstructive Pulmonary Disease (COPD)
NCT00147082
Imperial College London
CompletedLung Volume Reductions Surgery (LVRS) Study
NCT00018525
US Department of Veterans AffairsN/A
RecruitingEmphysema Research Registry and Biosample Repository
NCT00307281
University of Pittsburgh
TerminatedEvaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema
NCT00675454
Washington University School of Medicine
CompletedFeasibility of Retinoic Acid Treatment in Emphysema (FORTE)
NCT00000621
National Heart, Lung, and Blood Institute (NHLBI)Phase 2
CompletedNational Emphysema Treatment Trial (NETT)
NCT00000606
National Heart, Lung, and Blood Institute (NHLBI)Phase 3
CompletedCharacterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
NCT00001462
National Heart, Lung, and Blood Institute (NHLBI)
CompletedMedication Adherence in COPD--A Self-Regulation Study
NCT00005717
National Heart, Lung, and Blood Institute (NHLBI)
CompletedEmphysema: Physiologic Effects of Nutritional Support
NCT00000573
National Heart, Lung, and Blood Institute (NHLBI)Phase 2
CompletedAlpha1-antitrypsin Deficiency Registry
NCT00005292
National Heart, Lung, and Blood Institute (NHLBI)
CompletedTucson Epidemiology Study of Chronic Obstructive Lung Diseases
NCT00005279
National Heart, Lung, and Blood Institute (NHLBI)
CompletedHonolulu Heart Program
NCT00005123
National Heart, Lung, and Blood Institute (NHLBI)
CompletedCost-Effectiveness of Lung Volume Reduction Surgery
NCT00013156
US Department of Veterans AffairsPhase 2